Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Samer Imad Mohammed, Ali Lateef Jasim, Mohammad Yawuz Jamal & Saad Abdulrahman Hussain. (2023) Factors Influencing Adalimumab Treatment Response in Patients with Rheumatoid Arthritis: The Future of Clinical Expertise. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 5, pages 192-204.
Crossref
Crossref
Young Ho Lee & Gwan Gyu Song. (2023)
Association between the functional
FCGR3A
F158V
and
FCGR2A
R131H
polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta‐analysis
. International Journal of Rheumatic Diseases 26:7, pages 1295-1304.
Crossref
Crossref
Ines Mahmoud, Myriam Moalla, Aicha Ben Tekaya, Selma Bouden, Leila Rouached, Rawdha Tekaya, Olfa Saidane, Yousr Gorji, Mohamed Elleuch, Ahmed Laatar, Wafa Hamdi, Leila Abdelmoula & Imen Sfar. (2023) Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to Fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients. Drug Metabolism and Personalized Therapy 38:2, pages 155-162.
Crossref
Crossref
Philippa D. K. Curry, Andrew P. Morris, Anne Barton & James Bluett. (2022) Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?. The Pharmacogenomics Journal 23:1, pages 1-7.
Crossref
Crossref
Jacqueline So, Ann-Sophie De Craemer, Dirk Elewaut & Lai-Shan Tam. (2022) Spondyloarthritis: How far are we from precision medicine?. Frontiers in Medicine 9.
Crossref
Crossref
Paul G. Kremer & Adam W. Barb. (2022) The weaker-binding Fc γ receptor IIIa F158 allotype retains sensitivity to N-glycan composition and exhibits a destabilized antibody-binding interface. Journal of Biological Chemistry 298:9, pages 102329.
Crossref
Crossref
Gregor Jezernik, Mario Gorenjak & Uroš Potočnik. (2022) Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis. Biomedicines 10:8, pages 1808.
Crossref
Crossref
Zhuqian Wang, Jie Huang, Duoli Xie, Dongyi He, Aiping Lu & Chao Liang. (2021) Toward Overcoming Treatment Failure in Rheumatoid Arthritis. Frontiers in Immunology 12.
Crossref
Crossref
Augusta Ortolan, Giacomo Cozzi, Mariagrazia Lorenzin, Paola Galozzi, Andrea Doria & Roberta Ramonda. (2021) The Genetic Contribution to Drug Response in Spondyloarthritis: A Systematic Literature Review. Frontiers in Genetics 12.
Crossref
Crossref
Noelia Márquez Pete, María del Mar Maldonado Montoro, Cristina Pérez Ramírez, Fernando Martínez Martínez, Juan Enrique Martínez de la Plata, Abdelali Daddaoua & Alberto Jiménez Morales. (2021) Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine 11:6, pages 573.
Crossref
Crossref
Charalabos Antonatos, Eleana F Stavrou, Evangelos Evangelou & Yiannis Vasilopoulos. (2021) Exploring pharmacogenetic variants for predicting response to anti-TNF therapy in autoimmune diseases: a meta-analysis. Pharmacogenomics 22:7, pages 435-445.
Crossref
Crossref
Xin Wu, Xiaobao Sheng, Rong Sheng, Hongjuan Lu & Huji Xu. (2019) Genetic and clinical markers for predicting treatment responsiveness in rheumatoid arthritis. Frontiers of Medicine 13:4, pages 411-419.
Crossref
Crossref
Young Ho Lee, Sung Jae Choi, Jong Dae Ji & Gwan Gyu Song. (2016)
Associations between functional
FCGR2A
R131H and
FCGR3A
F158V polymorphisms and responsiveness to TNF blockers in spondyloarthropathy, psoriasis and Crohn's disease: a meta-analysis
. Pharmacogenomics 17:13, pages 1465-1477.
Crossref
Crossref
M Fabris, L Quartuccio, C Fabro, S Sacco, S Lombardi, R Ramonda, D Biasi, D Punzi, S Adami, I Olivieri, F Curcio & S De Vita. (2015) The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis. The Pharmacogenomics Journal 16:3, pages 238-242.
Crossref
Crossref
Bart V. J. Cuppen, Paco M. J. Welsing, Jan J. Sprengers, Johannes W. J. Bijlsma, Anne C. A. Marijnissen, Jacob M. van Laar, Floris P. J. G. Lafeber & Sandhya C. Nair. (2016) Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability. Rheumatology 55:5, pages 826-839.
Crossref
Crossref
Meghna Jani, Anne Barton & Pauline Ho. (2015) Pharmacogenetics of Treatment Response in Psoriatic Arthritis. Current Rheumatology Reports 17:7.
Crossref
Crossref
Cristina Lucía Dávila-Fajardo, Tahar van der Straaten, Rene Baak-Pablo, Catalina Medarde Caballero, Jose Cabeza Barrera, Tom W Huizinga, Henk-Jan Guchelaar & Jesse J Swen. (2015)
FcGR
genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis
. Pharmacogenomics 16:4, pages 373-381.
Crossref
Crossref
Ariana Montes, Eva Perez-Pampin, Beatriz Joven, Patricia Carreira, Antonio Fernández-Nebro, María del Carmen Ordóñez, Federico Navarro-Sarabia, Virginia Moreira, Yiannis Vasilopoulos, Theologia Sarafidou, Rafael Caliz, Miguel Angel Ferrer, Juan D Cañete, Arturo R de la Serna, Berta Magallares, Javier Narváez, Juan J Gómez-Reino & Antonio Gonzalez. (2015)
FCGR
polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors
. Pharmacogenomics 16:4, pages 333-345.
Crossref
Crossref
Young Ho Lee, Sang-Cheol Bae & Gwan Gyu Song. (2014) Functional FCGR3A 158 V/F and IL-6 −174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis. Rheumatology International 34:10, pages 1409-1415.
Crossref
Crossref
R. Zhang, M. Luan, Z. Shang, L. Duan, G. Tang, M. Shi, W. Lv, H. Zhu, J. Li, H. Lv, M. Zhang, G. Liu, H. Chen & Y. Jiang. (2014) RADB: a database of rheumatoid arthritis-related polymorphisms. Database 2014:0, pages bau090-bau090.
Crossref
Crossref
José Francisco Zambrano-Zaragoza, Juan Manuel Agraz-Cibrian, Christian González-Reyes, Ma. de Jesús Durán-Avelar & Norberto Vibanco-Pérez. (2013) Ankylosing Spondylitis: From Cells to Genes. International Journal of Inflammation 2013, pages 1-16.
Crossref
Crossref
María José Morales-Lara, Juan D. Cañete, Daniel Torres-Moreno, María Victoria Hernández, Francisco Pedrero, Raquel Celis, María Sergia García-Simón & Pablo Conesa-Zamora. (2012) Effets des polymorphismes des gènes TRAILR1 et TNFR1A sur la réponse au traitement anti-TNF chez les patients atteints de polyarthrite rhumatoïde et de rhumatisme psoriasique. Revue du Rhumatisme 79:6, pages 545-550.
Crossref
Crossref
María José Morales-Lara, Juan D. Cañete, Daniel Torres-Moreno, María Victoria Hernández, Francisco Pedrero, Raquel Celis, María Sergia García-Simón & Pablo Conesa-Zamora. (2012) Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis. Joint Bone Spine 79:6, pages 591-596.
Crossref
Crossref
JULIO RAMÍREZ, JOSÉ LUIS FERNÁNDEZ-SUEIRO, RAQUEL LÓPEZ-MEJÍAS, CARLOS MONTILLA, MAITE ARIAS, CONCEPCIÓN MOLL, MERCÉ ALSINA, RAIMON SANMARTI, FRANCISCO LOZANO & JUAN D. CAÑETE. (2012)
FCGR2A/CD32A
and
FCGR3A/CD16A
Variants and EULAR Response to Tumor Necrosis Factor-α Blockers in Psoriatic Arthritis: A Longitudinal Study with 6 Months of Followup
. The Journal of Rheumatology 39:5, pages 1035-1041.
Crossref
Crossref